ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NAUT vs CTKB // FREE CASH FLOW YIELD

Nautilus Biotechnology Inc. (NASDAQ) VS. Cytek Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: NAUT 0 — CTKB 4
▲ FREE CASH FLOW YIELD LEADER: CTKB
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NAUT VS. CTKB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NAUT CTKB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 51.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -12.70% -22.30 CTKB /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -12.99% -1.07% -11.92 CTKB /fcf-yield <GO>
Operating Margin — -20.00% — TIE /operating-margins <GO>
Net Profit Margin — -33.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 0.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.76 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.4 65.6 -8.20 CTKB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $399.9M $818.9M -$418.9M CTKB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NAUT REV CTKB REV NAUT GROSS % CTKB GROSS % NAUT FCF CTKB FCF
FY 2025 $0 $201.5M — 51.8% -$52.0M -$8.8M
FY 2024 $0 $200.5M — 55.4% -$61.3M $21.9M
FY 2023 $0 $193.0M — — -$51.7M $5.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NAUT // BETA —
CTKB // BETA —